Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A.
ESO Acquires d2i, Accelerating Emergency Intelligence to Drive Performance and Improve Outcomes Across Fire, EMS, and Health Systems
The Combined Platform will Create Connected Intelligence Across the Full Emergency Lifecycle
ESO Solutions, Inc., a leading data services and software company serving fire departments, EMS, hospitals, and government agencies, today announced it has acquired d2i, a healthcare performance improvement company that transforms siloed electronic medical record (EMR), revenue cycle management, scheduling, and patient experience data into operationally actionable insights for emergency departments and hospitals.
Health systems and emergency services generate vast amounts of data across dispatch, field care, and hospital settings. However, that data remains fragmented, limiting the ability to understand what drives patient outcomes and experience, or operational improvements such as emergency department boarding, throughput, or provider performance. ESO’s acquisition of d2i advances ESO’s vision of building end-to-end emergency intelligence—from understanding community risk, dispatch, response, incident management, prehospital, emergency department, hospital, and post-acute care.
“This acquisition enables ESO to be the first in our industry to offer connected intelligence from the community risk and initial call through the emergency department, hospital care, and beyond,” said Eric Beck, CEO at ESO. “d2i is a recognized leader in ED and hospital performance analytics. With ESO and d2i coming together, the combined data represents the largest integrated prehospital and hospital data asset available to drive emergency intelligence. Together, we can close the loop between what happens in the field and what happens in the hospital and in the post-acute setting, unlocking a level of insight that simply has not been available to emergency services until now.”
The acquisition builds on ESO’s existing partnerships with more than 3,000 hospitals as well as ESO Health Data Exchange, a leading EMS interoperability solution that connects hospitals with emergency services providers in real-time across the U.S. and the globe. d2i supports more than 60 million hospital encounters and manages 10 billion data points in its warehouse…
Full release here, originally announced April 7th, 2026.
D2 Solutions Acquires ProModRx to Expand Technology and Services Supporting Enhanced Patient Access and Engagement
ProModRx Adds Infrastructure and Capabilities that Strengthen D2’s Support from Initial Access through Ongoing Patient Services
D2 Solutions, a healthcare consulting and technology company focused on market access, reimbursement, and patient support, has acquired ProModRx, a cloud-based technology platform designed to help speed patient access to prescription medications.
The acquisition expands D2’s services to better assist pharmaceutical and medical device manufacturers, traditional hubs, and pharmacies across the full scope of the patient journey. That support includes therapy initiation, prescription capture, electronic benefits verification, prior authorization support, dispensing coordination, and ongoing patient engagement.
The need for stronger connectivity between manufacturers, prescribers, and patients is significant. In recent D2 research, 21% of adults delayed starting a prescribed medication because of confusion or access issues. In addition, 11% of respondents did not pick up their medication from the pharmacy, 12% skipped doses, and 8% stopped treatment earlier than planned.
The deal also comes as healthcare stakeholders – especially patients, providers, and manufacturers – face growing pressure to manage access, reimbursement, and fulfillment amid a more complex pricing and policy environment.
“D2’s focus has always been responding to market demands and the needs of our partners by helping address gaps in market access, operational support, and patient services,” said Dean Erhardt, D2 Founder and CEO…
Full release here, originally announced April 16th, 2026.
No comments:
Post a Comment